Efficacy and safety of switching to pasireotide in acromegaly patients controlled with pegvisomant and somatostatin analogues: PAPE extension study

Muhammad Arif; Eva Coopmans; Patric Delhanty; Alof Dallenga; Iain Haitsma; J.A.M.J.L. Janssen; AJ (Aart-Jan) van der Lely; S.J.C.M.M. Neggers

doi:10.1530/eje-18-0353

Efficacy and safety of switching to pasireotide in acromegaly patients controlled with pegvisomant and somatostatin analogues: PAPE extension study

Muhammad Arif, Eva Coopmans, Patric Delhanty, Alof Dallenga, Iain Haitsma, J.A.M.J.L. Janssen, AJ (Aart-Jan) van der Lely, S.J.C.M.M. Neggers

Research output: Contribution to journal › Article › Academic › peer-review

33 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	269-277
Number of pages	9
Journal	European Journal of Endocrinology
Volume	179
Issue number	5
DOIs	https://doi.org/10.1530/eje-18-0353
Publication status	Published - 2018

Access to Document

10.1530/eje-18-0353

http://hdl.handle.net/1765/111169

Cite this

Arif, M., Coopmans, E., Delhanty, P., Dallenga, A., Haitsma, I., Janssen, J. A. M. J. L., van der Lely, AJ., & Neggers, S. J. C. M. M. (2018). Efficacy and safety of switching to pasireotide in acromegaly patients controlled with pegvisomant and somatostatin analogues: PAPE extension study. European Journal of Endocrinology, 179(5), 269-277. https://doi.org/10.1530/eje-18-0353

@article{49efee1034fa4b2998c8b1aab3fc7e6b,

title = "Efficacy and safety of switching to pasireotide in acromegaly patients controlled with pegvisomant and somatostatin analogues: PAPE extension study",

author = "Muhammad Arif and Eva Coopmans and Patric Delhanty and Alof Dallenga and Iain Haitsma and J.A.M.J.L. Janssen and {van der Lely}, {AJ (Aart-Jan)} and S.J.C.M.M. Neggers",

year = "2018",

doi = "10.1530/eje-18-0353",

language = "Undefined/Unknown",

volume = "179",

pages = "269--277",

journal = "European Journal of Endocrinology",

issn = "0804-4643",

publisher = "Bioscientifica Ltd",

number = "5",

}

TY - JOUR

T1 - Efficacy and safety of switching to pasireotide in acromegaly patients controlled with pegvisomant and somatostatin analogues: PAPE extension study

AU - Arif, Muhammad

AU - Coopmans, Eva

AU - Delhanty, Patric

AU - Dallenga, Alof

AU - Haitsma, Iain

AU - Janssen, J.A.M.J.L.

AU - van der Lely, AJ (Aart-Jan)

AU - Neggers, S.J.C.M.M.

PY - 2018

Y1 - 2018

U2 - 10.1530/eje-18-0353

DO - 10.1530/eje-18-0353

M3 - Article

SN - 0804-4643

VL - 179

SP - 269

EP - 277

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

IS - 5

ER -